🇺🇸 FDA
Patent

US 8969565

Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use

granted A61KA61K31/5025A61P

Quick answer

US patent 8969565 (Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use) held by LEXICON PHARMACEUTICALS, INC. expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
LEXICON PHARMACEUTICALS, INC.
Grant date
Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/5025, A61P, A61P21/00, A61P25/00